Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Parse Biosciences

Parse Biosciences Welcomes Admera Health as Newest Member of Certified Service Provider Network
From Parse Biosciences
Via Business Wire
Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications
From Parse Biosciences
Via Business Wire
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
From Parse Biosciences
Via Business Wire
Parse Biosciences Partners with OMAPiX to Expand Access to Single Cell Sequencing
From Parse Biosciences
Via Business Wire
Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
From Parse Biosciences
Via Business Wire
Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually
From Parse Biosciences
Via Business Wire
In a Key Win for Parse, Patent Trial and Appeal Board Invalidates 10x Genomics Patent Claims
From Parse Biosciences
Via Business Wire
Kaitie Kramer Joins Parse Biosciences as Vice President of Marketing
From Parse Biosciences
Via Business Wire
Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia
From Parse Biosciences
Via Business Wire
Parse Biosciences Launches Certified Service Provider Program
From Parse Biosciences
Via Business Wire
Parse Biosciences Announces Partnership with Gencell Pharma to Extend its Reach in South America
From Parse Biosciences
Via Business Wire
Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing
From Parse Biosciences
Via Business Wire
Parse Biosciences Launches Single Cell Immune Profiling Products
From Parse Biosciences
Via Business Wire
Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech
From Parse Biosciences
Via Business Wire
Parse Biosciences Launches Evercode Whole Transcriptome Version 3, Boosting Usability and Performance
From Parse Biosciences
Via Business Wire
Parse Biosciences Partners with INTEGRA Biosciences for Automated Single Cell Workflows
From Parse Biosciences
Via Business Wire
Parse Biosciences Acquires Biomage
From Parse Biosciences
Via Business Wire
Parse Biosciences Closes $50 Million of Financing to Fuel Continued Worldwide Growth
From Parse Biosciences
Via Business Wire
Parse Biosciences Extends Global Reach with India-based Spinco Biotech Partnership
From Parse Biosciences
Via Business Wire
Julie Gerardi Joins Parse Biosciences as Vice President of Business Development
From Parse Biosciences
Via Business Wire
Parse Biosciences Launches CRISPR Detect
From Parse Biosciences
Via Business Wire
Parse Biosciences Expands Global Access to Israel
From Parse Biosciences
Via Business Wire
Parse Biosciences Announces Evercode TCR and Gene Capture
From Parse Biosciences
Via Business Wire
Parse Biosciences to Participate in Canaccord Genuity Investor Conference
From Parse Biosciences
Via Business Wire
Parse Biosciences Announces Cloud Analysis Platform to Simplify Single Cell Analysis
From Parse Biosciences
Via Business Wire
Parse Biosciences Releases Whole Transcriptome Version 2 Chemistry with Marked Performance Enhancements
From Parse Biosciences
Via Business Wire
Parse Biosciences Announces Partnership with Molecular Diagnostics Korea
From Parse Biosciences
Via Business Wire
Parse Biosciences Raises $41.5M Series B Round to Scale Single-Cell Sequencing Products and Expand Product Portfolio
From Parse Biosciences
Via Business Wire
Parse Biosciences Announces Partnership With Research Instruments Group to Offer RNA-Seq Kits in Singapore and Southeast Asia Region
From Parse Biosciences
Via Business Wire
Parse Biosciences Unveils 1,000,000 Cell scRNA-seq Kit
From Parse Biosciences
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.